Actively Recruiting
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
Led by Université de Sherbrooke · Updated on 2026-04-13
40
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
Sponsors
U
Université de Sherbrooke
Lead Sponsor
D
Dalhousie University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Canadians spend most of their day in sedentary postures (i.e., sitting, lying, reclining). While the beneficial impacts of physical activity on the heart are well-established, less is known about the consequences during time spent in sedentary postures. Currently, we know that spending time in a bout of uninterrupted sitting disrupts blood pressure regulation. However, it is unknown if there are any 'carry over' effects following uninterrupted sitting bouts (i.e., over the next 24-hours). The release of chemicals from arteries controls how stiff or relaxed they are and is important for controlling blood pressure. This is especially true for arteries directly impacted by sitting (e.g., the popliteal artery behind the knee) and that send blood to the brain (e.g., the carotid artery). We have also established that endothelial-derived hyperpolarizing factors (EDHF, chemicals that relax the artery) are important for the relaxation of the artery the popliteal artery. However, we do not know if the effects of EDHFs on this artery are decreased during or after a bout of uninterrupted sitting. A bout of prolonged sitting also causes blood pressure and fluctuations in blood pressure to increase. Importantly, we reported that fluctuations in blood pressure caused by sitting are higher in young males versus females, but average blood pressure was higher among females. These findings suggest that sitting exerts sex differences in the control of blood pressure. Importantly, these effects were only demonstrated during the 2-hour bout of sitting. As such, it is unknown whether blood pressure is negatively impacted after prolonged sitting. The proposed study will determine the impact of EDHFs on blood pressure regulation following a 2-hour bout of prolonged sitting among a group of healthy males and females. Continuous heart rate (via electrocardiogram) and blood pressure (via finger cuff), as well as blood flow from the common carotid artery (in the neck), middle cerebral artery (in the brain) and popliteal artery (behind the knee) will be measured before and after sitting (via ultrasound). The ability of the popliteal artery to relax will be assessed using ultrasound following the release of a pressure cuff. Finally, 24-hour blood pressure and heart rate will be recorded after sitting using a monitor worn for 24-hours. The role of EDHFs will be investigated by comparing 1) baseline blood flow and blood pressure responses (no sitting), 2) blood pressure responses following a 2-hour bout of sitting, and 3) the blood pressure responses following a 2-hour bout of sitting while suppressing the release of EDHFs (via fluconazole ingestion).
CONDITIONS
Official Title
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 18 and 65 years
- Body mass index below 40 kg/m2 (non-obese)
- Have not smoked nicotine or marijuana products most days in the past 6 months
- No diagnosis of cardiovascular, cerebrovascular, respiratory, or metabolic diseases
- Have normal blood pressure (normotensive)
- Not currently taking medications for cardiovascular, metabolic, pulmonary, or neurological disorders, and not regularly taking sildenafil
- No allergy to the adhesive used for activity monitors
- Not pregnant or breastfeeding
- Not regularly taking antifungals, certain heartburn, depression, antibiotic, lipid-lowering, anti-inflammatory medications, or vitamin A supplements
You will not qualify if you...
- Younger than 18 years or older than 65 years
- Body mass index over 40 kg/m2 (obese category II)
- Smoked nicotine or marijuana products most days in the past 6 months
- Diagnosed with cardiovascular, cerebrovascular, respiratory, or metabolic diseases
- Hypertension (resting systolic >139 mmHg or diastolic >89 mmHg)
- Hypotension (resting systolic <90 mmHg or diastolic <60 mmHg)
- History of fainting or dizziness during sitting or standing
- Taking prescribed cardiovascular, metabolic, pulmonary, or neurological medications, including hormone replacement therapy
- Allergy to adhesive used for activity monitors
- Pregnant or breastfeeding females
- Regularly taking sildenafil or medications that increase nitric oxide effects
- Regular use of certain antifungals, heartburn, depression, antibiotic, lipid-lowering, anti-inflammatory medications, or vitamin A supplements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dalhousie University
Halifax, Nova Scotia, Canada, B3H4R2
Actively Recruiting
Research Team
M
Molly K Courish, MSc, PhD(s)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here